Mixture effects on the dermal absorption of biocides.
Authors
Baynes RE; Riviere JE; Xia X-R; Smith C
Source
Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, R01-OH-003669, 2009 Jan; :1-29
Workers in the metal-machining industry are frequently reported to develop occupational dermatitis amongst other adverse health effects following exposure to metal-working fluids. The primary focus of this research project was to quantify physicochemical interactions modulating dermal absorption of industrial irritants (e.g., biocides/preservatives) in metal working fluid (MWF) mixtures following dermal exposure. Our laboratory developed a novel membrane-coated fiber (MCF) technique that quantifies not only the partitioning behavior of these toxicologically important solutes but also other solvatochromatic descriptors (e.g., polarity, hydrogen bonding) that more accurately reflect the mechanistic interaction between the irritant, industrial formulation/mixtures, and skin. This approach allowed for quantification of mixture-membrane interactions that can be used as a predictive tool of dermal disposition of irritating biocides or preservatives relevant to worker exposure in the metal machining industry. Another major goal of the study was to evaluate the utility of the membrane-coated fibers (MCF) to capture simple mixture-induced effects and to correlate these changes to dermal permeability using a solvatochromatic approach to quantify physicochemical and biological interactions. Our major research findings can be summarized as follows: (1) Calibrated a series of membrane coated fibers (MCFs) with a limited data set, and demonstrated solvent, surfactant, and MWF formulation effects and dilution effects on solute/biocide partitioning into these chemically diverse MCFs. (2) The solvatochromatic or linear solvation energy relationship (LSER) approach adequately predicted the dermal permeability of several solutes and phenolic biocides in soluble oil and synthetic MWF. This research demonstrated that formulation-specific strength coefficients (r p a b v) predicted (R2 = 0.75 to 0.83) changes in the dermal permeability of phenolic biocides when formulated with commercial metalworking fluid (MWF) formulations or 50% ethanol. (3) MWF biocide permeability in skin can be significantly reduced as the MWF concentration increases. This can be of occupational concern as MWF dilutions in the work place can range from 1-20% with the more dilute formulation enhancing permeability of some classes of biocides. Permeation of chemicals was higher in generic synthetic MWF when compared to a soluble oil MWF. This suggests that a soluble oil MWF may be safer than a synthetic MWF in regards to dermal permeation of phenolic biocides/solutes to allow for an increased potential of systemic toxicity. Therefore, one may conclude that a synthetic type of formulation has more potential to cause contact dermatitis and possibly induce systemic toxicological effects. (4) Demonstrated that large and hydrophobic biocides tend to be retained in the commercial MWFs while the more basic biocides tend to permeate through skin. (5) Demonstrated a strong correlation between changes in skin permeability and the changes in partitioning in an MCF-array for simple mixtures containing either ethanol or the surfactant, sodium lauryl sulfate (SLS). This MCF-array, which is a high-throughput and reproducible system may be applicable to predicting skin permeability of chemicals from industrial formulations such as metal-working fluids. The data from this research can be used by regulators, manufacturers, and users of metal working fluids (MWF) and biocides to amend their formulations and recommend dilutions such that dermal absorption of biocides and other additives are least likely to occur and result in contact dermatitis and/or other systemic health effects.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.